Medicine

Indication

• Diabetic foot ulcer, Burn, Pressure Ulcer, Mucositis, Radiation ulcer, Broad range of acute and chronic wounds

Experimentation

Specification

Research Information

• Therapeutic Effect of the Recombinant Human Epidermal Growth Factor (rhEGF) in Pressure Ulcer.
• Using Recombinant Human Epidermal Growth Factor with Standard of Good Care for Diabetic Foot Ulcers in Inoperable Patients.
• Effect of epidermal growth factor against radiotherapy-induced oral mucositis in rats.
• Expression of tumor necrosis factor-alpha and cyclooxygenase-2 mRNA in porcine split-thickness wounds treated with epidermal growth factor by quantitative real-time PCR.
• Effects of Recombinant Human Epidermal Growth Factor on the Proliferation and Radiation Survival of Human Fibroblast Cell Lines in Vitro.
• Effects of Recombinant Human Epidermal Growth Factor on the Proliferation and Radiation Survival of Human Fibroblast Cell Lines in Vitro.
• Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers.
• Cho JH, Lew DH, Kim YS, Tark KC. Treatment of Acute and Chronic Wound in Immunodeficiency Patients Using Easyef(R) (EGF)
• The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model
• Acute necrotic stomatitis (noma) associated with methicillin-resistant Staphylococcus aureus infection in a newly acquired rhesus macaque (Macaca mulatta
• Kim EK, Li G, Lee TJ, Hong JP. The effect of human adipose-derived stem cells on healing of ischemic wounds in a diabetic nude mouse model
• The preventive effect of recombinant human growth factor (rhEGF) on the recurrence of radiodermatitis. Therapeutic effects of recombinant human epidermal growth factor (rhEGF) in a murine model of concurrent chemo- and radiotherapy-induced oral mucositis.
• Early recombinant human epidermal growth factor treatment recovers the irradiation-induced decrease of Na+ absorption prior to the definite histological mucositis.
• Epidermal growth factor induces cell death in the absence of overexpressed epidermal growth factor receptor and ErbB2 in various human cancer cell lines.
• Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy,
• The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results.
• Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
• Recombinant human epidermal growth factor accelerates recovery of mouse small intestinal mucosa after radiation damage.
• The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds.
• The Effect of Recombinant Human Epidermal Growth Factor on Cisplatin and Radiotherapy Induced Oral Mucositis in Mice.
• The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer.